W S Vargas1, K G Noble2, B Banwell3, P De Jager1. 1. Department of Neurology, Center for Translational and Computational Neuroimmunology, Columbia University Irving Medical Center, New York, NY, USA. 2. Columbia University Teacher's College, New York, NY, USA. 3. Department of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Abstract
BACKGROUND: Limited data suggest that adolescents with multiple sclerosis (MS) frequently discontinue school. While it is known that cognitive impairment occurs in 30% to 50% of children with MS, the functional impact of childhood MS on academic achievement is virtually unknown. OBJECTIVE: To that end, this paper builds an evidence-based argument for evaluating educational outcomes in children with MS. METHODS: This will be accomplished through (a) a review of pediatric MS and its cognitive consequences; (b) a selective review of the utility of neuropsychological batteries in assessing academic outcomes in pediatric populations in general; and (c) a brief overview of modifiable factors that have a potential benefit on school outcomes in children with MS. CONCLUSION: Scholastic achievement should be assessed as part of the routine cognitive screening of children and adolescents with MS.
BACKGROUND: Limited data suggest that adolescents with multiple sclerosis (MS) frequently discontinue school. While it is known that cognitive impairment occurs in 30% to 50% of children with MS, the functional impact of childhood MS on academic achievement is virtually unknown. OBJECTIVE: To that end, this paper builds an evidence-based argument for evaluating educational outcomes in children with MS. METHODS: This will be accomplished through (a) a review of pediatric MS and its cognitive consequences; (b) a selective review of the utility of neuropsychological batteries in assessing academic outcomes in pediatric populations in general; and (c) a brief overview of modifiable factors that have a potential benefit on school outcomes in children with MS. CONCLUSION: Scholastic achievement should be assessed as part of the routine cognitive screening of children and adolescents with MS.
Authors: C Till; R Ghassemi; B Aubert-Broche; A Kerbrat; D L Collins; S Narayanan; D L Arnold; M Desrocher; J G Sled; B L Banwell Journal: Neuropsychology Date: 2011-05 Impact factor: 3.295
Authors: W S MacAllister; A L Belman; M Milazzo; D M Weisbrot; C Christodoulou; W F Scherl; T E Preston; C Cianciulli; L B Krupp Journal: Neurology Date: 2005-04-26 Impact factor: 9.910
Authors: Stephanie A Grover; Berengere Aubert-Broche; Dumitru Fetco; D Louis Collins; Douglas L Arnold; Marcia Finlayson; Brenda L Banwell; Robert W Motl; E Ann Yeh Journal: Neurology Date: 2015-08-12 Impact factor: 9.910